Search filters

List of works by Alba A. Brandes

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

scientific article

A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma

scientific article published on 21 February 2016

A Randomized Controlled Trial of Tong Len Meditation Practice in Cancer Patients: Evaluation of a Distant Psychological Healing Effect

scientific article published on 26 October 2015

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma

scientific article published on 28 September 2018

A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy.

scientific article published on 11 February 2014

A commentary on interstitial pneumonitis induced by docetaxel: clinical cases and systematic review of the literature

scientific article published on 25 June 2015

A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia.

scientific article

A multicenter study of the prognosis and treatment of adult brain ependymal tumors.

scientific article published in March 2004

A prospective study on glioblastoma in the elderly

scientific article

ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA

AT-11FINAL RESULTS FROM THE RANDOMIZED PHASE II TRIAL AVAREG (ML25739) WITH BEVACIZUMAB (BEV) OR FOTEMUSTINE (FTM) IN RECURRENT GBM.

scientific article

AT-18SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEWLY DIAGNOSED GLIOBLASTOMA [GBM])

AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

scientific article published on 6 March 2016

Accuracy of technetium-99m sestamibi scintimammography and X-ray mammography in premenopausal women with suspected breast cancer.

scientific article published on 23 October 2001

Adding temozolomide to radiotherapy prolongs survival in people with glioblastoma.

scientific article published on 19 October 2005

Adjuvant chemotherapy in the treatment of high grade gliomas.

scientific article

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

scientific article

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

scientific article

Adjuvant temozolomide: how long and how much?

scientific article published in May 2008

Adjuvant therapy in glioblastomas: false steps and real advances.

scientific article

Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).

scientific article published on 19 March 2009

Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches.

scientific article

Advances in malignant glioma drug discovery

scientific article published on 07 June 2011

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): data report from Italy

scientific article

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas.

scientific article published on January 2004

Association between response to primary treatments and MGMT status in glioblastoma

scientific article

Bevacizumab in brain tumors: ready for primetime?

scientific article published in October 2009

Bevacizumab in recurrent glioblastoma: open issues

scientific article published on 11 September 2015

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma

scientific article published in February 2014

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

scientific article

Brain metastases from non-small-cell lung cancer: is there room for improvement?

scientific article published in April 2012

Breast cancer risk in symptomatic women spontaneously undergoing clinical breast examination

scientific article published on 01 July 2003

Burnout in medical oncology during the COVID-19 pandemic

scientific article published on 23 December 2020

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling

scientific article published on 01 January 2020

Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?

scientific article published on May 2014

Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II study.

scientific article

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme ⬇️

scientific article published on January 15, 1998

Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial

scientific article published on 15 August 2011

Cardiovascular safety of VEGF-targeting therapies: current evidence and handling strategies

scientific article published on 14 June 2010

Challenges and progress in the treatment of adult medulloblastomas.

scientific article published in April 2007

Chemotherapy in brain metastases of lung and breast cancer

Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome?

scientific article published on 12 June 2008

Chemotherapy in patients with recurrent and progressive central neurocytoma

scientific article published on 01 January 2000

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

scientific article

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

scientific article published on 01 June 1990

Clinical end points in recurrent glioblastoma: are antiangiogenic agents friend or foe? ⬇️

scientific article published on May 1, 2011

Clinical, pathological and therapeutic aspects of oligodendroglioma ⬇️

scientific article published on April 1, 1998

Contribution of microRNA analysis to characterisation of pancreatic lesions: a review

scientific article published on 27 August 2015

Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

scientific article

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study

scientific article published on 5 September 2006

Current clinical management of gastrointestinal stromal tumors

scientific article published in August 2004

Current management and prognostic factors for adult ependymoma

scientific article

Cytologically confirmed splenic metastases in breast cancer

scientific article published on November 2012

Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma.

scientific article

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

scientific article published on 09 April 2008

EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma

scientific article published on 01 December 2019

EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer

scientific article

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma

scientific article

EORTC study 26041-22041: phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma

scientific article

EORTC topics in neurooncology: The long path from a focus on neurological complications of cancer towards molecularly defined trials and therapies in neurooncology

ET-12PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA.

scientific article published in November 2014

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study

scientific article

Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.

scientific article published in November 2004

End points for Phase II trials in recurrent glioblastoma: the cornerstone for a new era.

scientific article

Epidemiology of glial and non-glial brain tumours in Europe

scientific article published on 7 January 2012

Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma.

scientific article

Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments

scientific article published on February 2008

European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme.

scientific article published in December 2003

Fertility preservation in women with CNS tumors

scientific article published on 11 April 2017

Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy

scientific article published on 21 May 2020

Fine-needle aspiration cytology of adrenal masses in noncancer patients

scientific article published on 01 October 2001

First-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia

scientific article

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

scientific article

Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.

scientific article

Gangliogliomas: recent advances in classification and treatment

Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

scientific article published on 13 March 2007

Glioblastoma in adults

scientific article published on 03 April 2008

Glioblastoma in the elderly: current and future trends

scientific article published on 5 October 2006

Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial

scientific article

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

scientific article published on 26 September 2016

High-dose chemotherapy with bone marrow rescue for high-grade gliomas in adults.

scientific article

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

scientific article published on 18 September 2009

Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas

scientific article published on 25 July 2020

How to face cancer treatment in the COVID-19 era

scientific article published on 06 May 2020

Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

scientific article published on 11 December 2015

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

scientific article

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

scientific article published on 10 May 2019

Immunotherapy in elderly patients: should we stay or should we go?

scientific article published on 14 April 2020

Immunotherapy in head and neck cancer: evidence and perspectives

scientific article published in December 2017

Immunotherapy response assessment in neuro-oncology: a report of the RANO working group

scientific article

In Reply

Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study ⬇️

scientific article published on September 1, 1997

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer

scientific article published on 21 April 2016

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

scientific article

LTBK-04 FIRST RESULTS OF THE RANDOMIZED PHASE II STUDY ON DEPATUX –M ALONE, DEPATUX-M IN COMBINATION WITH TEMOZOLOMIDE AND EITHER TEMOZOLOMIDE OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA: FIRST REPORT FROM INTELLANCE 2/EORTC TRIAL 1410

scientific article published on 17 November 2017

Lomustine and Bevacizumab in Progressive Glioblastoma

scientific article published in November 2017

Long-term results of a prospective study on the treatment of medulloblastoma in adults.

scientific article

MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years

scientific article published on 14 March 2014

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

scientific article published on 01 May 2006

MB-52RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) COMMITTEE GUIDELINES FOR RESPONSE ASSESSMENT IN MEDULLOBLASTOMA AND OTHER LEPTOMENINGEAL SEEDING TUMORS.

scientific article published on 30 May 2016

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

scientific article published on 08 December 2009

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

scientific article

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

scientific article published in May 2008

Maintenance therapy in non-small cell lung cancer

scientific article published on 31 May 2015

Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients

scientific article published on 07 June 2020

Medulloblastoma and central nervous system germ cell tumors in adults: is pediatric experience applicable?

scientific article published on 14 August 2019

Medulloblastoma in adults: clinical characteristics and treatment.

scientific article

Medulloblastomas in adults: prognostic factors and lessons from paediatrics

scientific article published on December 2011

Metastatic process: the seed and the soil from bench to bedside

scientific article published in November 2013

Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes ⬇️

scientific article published on 29 September 2020

Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study: A report from EORTC study 26951.

scientific article

NCOG-19. NEUROCOGNITIVE OUTCOMES OF EORTC BRAIN TUMOR GROUP STUDY 26101 PHASE III TRIAL COMPARING THE COMBINATION OF LOMUSTINE AND BEVACIZUMAB WITH LOMUSTINE ALONE IN GLIOBLASTOMA PATIENTS WITH FIRST PROGRESSION

NI-26COMPARATIVE ANALYSIS OF THE RANO AND MACDONAD'S CRITERIA IN RECURRENT GLIOBLASTOMA TREATED IN THE RANDOMIZED PHASE II TRIAL AVAREG WITH BEVACIZUMAB OR FOTEMUSTINE.

scientific article published in November 2014

NIMG-51. RADIOLOGIC PHENOTYPES ARE TREATMENT SPECIFIC AND ASSOCIATED WITH SURVIVAL - EXPLORATORY ANALYSIS OF EORTC 26101

scientific article published on 6 November 2017

NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP.

scientific article

NIMG-75. NECROSIS DURING TREATMENT IS ASSOCIATED WITH WORSE SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS – POST HOC IMAGE ANALYSIS OF EORTC 26101

Neuro-oncology: Genetic variation in pediatric and adult brain tumors.

scientific article

Neuro-oncology: treatment decisions in elderly patients with glioblastoma.

scientific article

New Agents and New End Points for Recurrent Gliomas ⬇️

scientific article published on January 31, 2011

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cance

scientific article published on 26 July 2013

New drugs in the treatment of elderly patients with metastatic castration-resistance prostate cancer

scientific article

New molecular targets and novel anticancer treatments: emerging trends in neuro-oncology.

scientific article published in August 2006

New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.

scientific article

New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

scientific article published on 28 March 2012

New strategy developments in brain tumor therapy.

scientific article

Nitrosoureas in the Management of Malignant Gliomas

scientific article

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

scientific article published on 21 December 2007

Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria

scientific article

Non-cytotoxic therapies for malignant gliomas

scientific article

Novel therapeutics in adult malignant brain gliomas

scientific article

O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

scientific article

Optimal management of elderly patients with glioblastoma

scientific article published on 19 June 2012

Patient outcomes following second surgery for recurrent glioblastoma

scientific article

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

scientific article

Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial

scientific article published on 14 April 2015

Pharmacotherapy of Glioblastoma: Established Treatments and Emerging Concepts

scientific article published on 5 July 2017

Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma

scientific article published on 9 June 2017

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).

scientific article

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.

scientific article

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

scientific article

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study

scientific article published on October 2008

Phase II trial with BCNU plus alpha-interferon in patients with recurrent high-grade gliomas.

scientific article published in August 1997

Phosphorylated Acetyl-CoA Carboxylase is associated with clinical benefit with Regorafenib in relapsed glioblastoma: REGOMA Trial Biomarker Analysis

scientific article published on 09 June 2020

Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study

scientific article published on 03 January 2022

Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions

scientific article published on 01 November 2002

Post progression survival in glioblastoma: where are we?

scientific article published on November 2014

Postsurgical Approaches in Low-Grade Oligodendroglioma: Is Chemotherapy Alone Still an Option?

scientific article published on 18 February 2019

Practical management of bevacizumab-related toxicities in glioblastoma

scientific article

Prevalence of breast cancer in women with breast complaints. Retrospective analysis in a population of symptomatic patients

scientific article published on 01 November 2002

Prevalence of the single-nucleotide polymorphism rs11554137 (IDH1105GGT) in brain tumors of a cohort of Italian patients.

scientific article published on 13 March 2018

Primary brain tumors in the elderly population.

scientific article published in August 2011

Prognostic factors for anaplastic astrocytomas

scientific article

Prognostic impact of HER-2 Subclonal Amplification in breast cancer

scientific article published on 2 June 2017

Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group

scientific article published on 15 February 2012

Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study

scientific article

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma.

scientific article published on 31 August 2011

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference

scientific article

QLIF-27. THE ADDED VALUE OF HEALTH-RELATED QUALITY OF LIFE (HRQoL) AS A PROGNOSTIC INDICATOR OF OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN GLIOMA PATIENTS: A META-ANALYSIS BASED ON INDIVIDUAL PATIENT DATA FROM RANDOMIZED CONTROLLED TRIALS

QOL-07DESCRIPTION OF CLINICAL AND PATIENT REPORTED OUTCOMES ASSESSMENTS FROM A PHASE 3, MULTICENTER, RANDOMIZED TRIAL EVALUATING NIVOLUMAB MONOTHERAPY VERSUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA: CHECKMATE-143.

scientific article

QOLP-29. SYMPTOM CLUSTERS IN NEWLY DIAGNOSED GLIOMA PATIENTS: WHICH CLUSTERS ARE ASSOCIATED WITH FUNCTIONING AND GLOBAL HEALTH STATUS?

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

scientific article

Radiotherapy of the brain in elderly patients. Contra:.

scientific article published in March 2000

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

scientific article (publication date: 10 March 2005)

Raltitrexed-eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer.

scientific article

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

scientific article

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA

scientific article

Rare Primary Central Nervous System Tumors in Adults: An Overview

scientific article published on 26 June 2020

Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status

scientific article published on 2 February 2009

Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences

scientific article

Relationship between tumor markers CEA and CA 15-3, TNM staging, estrogen receptor rate and MIB-1 index in patients with pT1-2 breast cancer

scientific article published in September 2004

Resistance to antiangiogenic therapies

scientific article

Response Assessment in Medulloblastoma and Leptomeningeal Seeding Tumors: Recommendations from the Response Assessment in Pediatric Neuro-Oncology Committee

scientific article

Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

scientific article published on 01 June 2020

Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

scientific article published on 01 June 2020

Review of the prognostic factors in medulloblastoma of children and adults.

scientific article published on May 2004

Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications.

scientific article

Second surgery for recurrent glioblastoma: advantages and pitfalls

scientific article published on May 2013

Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

scientific article published in December 2004

Seroma prevention following axillary dissection in patients with breast cancer by using ultrasound scissors: a prospective clinical study

scientific article published in June 2004

Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma

scientific article published on 07 July 2016

Shedding light on adult medulloblastoma: current management and opportunities for advances

scientific article published on January 2014

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

scientific article published on March 2017

Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma

scientific article published on 24 May 2006

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

scientific article published on 01 November 2019

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

scientific article published on 3 October 2006

Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients

scientific article published on 06 July 2020

Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.

scientific article published in February 2001

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

scientific article published on 26 September 2016

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.

scientific article

Temozolomide in patients with glioblastoma at second relapse after first line nitrosourea-procarbazine failure: a phase II study

scientific article published in January 2002

Temozolomide rechallenge in recurrent glioblastoma: when is it useful?

scientific article published on 09 May 2018

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

scientific article published on 23 April 2008

The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.

scientific article

The European Organisation for Research and Treatment of Cancer strategy for new drug development in brain tumors.

scientific article published on December 2003

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria

scientific article published in May 2017

The Risk Assessment in Low-Grade Gliomas: An Analysis of the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG) criteria

scientific article published on 16 July 2018

The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials

scientific article published on 13 June 2019

The burden of oncology promises not kept in glioblastoma

The development of platinum compounds and their possible combination

scientific article published on 27 June 2006

The effect of re-operation on survival in patients with recurrent glioblastoma

scientific article published on March 2015

The metastatic process: a kaleidoscope of concepts

scientific article published in April 2014

The pathogenesis and treatment of brain metastases: a comprehensive review.

scientific article

The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.

scientific article

The prognostic role of gender and MGMT methylation status in glioblastoma patients: the female power

scientific article published on 11 January 2018

The role of bevacizumab in recurrent glioblastoma: new insights from randomized trials

scientific article

The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?

scientific article published on 25 June 2018

The role of gender in glioblastoma: does it matter?

The role of systemic and targeted therapies in brain metastases

scientific article

The treatment of adults with medulloblastoma: a prospective study

scientific article published in November 2003

The treatment of cranial germ cell tumours.

scientific article

Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview

scientific article

Third-line therapy in recurrent glioblastoma: is it another chance for bevacizumab?

scientific article published on 18 April 2018

Trastuzumab and lapatinib beyond trastuzumab progression for metastatic breast cancer: strategies and pitfalls

scientific article published on February 2010

Trastuzumab in CNS progressive metastatic breast cancer.

scientific article published in August 2007

Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts

scientific article

Treatment of brain metastases in uncommon tumors.

scientific article published in October 2004

Treatment of recurrent glioblastoma: state-of-the-art and future perspectives

scientific article published on 17 August 2020

Treatment of recurrent high-grade gliomas

scientific article published on December 2009

Treatment options for recurrent glioblastoma: pitfalls and future trends

scientific article published on May 2009

Unusual nasal and orbital involvement of glioblastoma multiforme: a case report and review of the literature.

scientific article published on January 1998

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study

scientific article published on 4 March 2016

Paulina is supported by:

About Paulina

Help